Integra LifeSciences (IART) Tops Q4 EPS by 3c, Revenues Beat; Offers FY19 EPS Mid-Point Guidance Above Consensus, FY19 Revenue Views Below Estimates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. META
4. SPY
5. IBM
6. MU
7. FDX
8. BLZE
9. NKE
10. PRIM

Go back to Integra LifeSciences (IART) Tops Q4 EPS by 3c, Revenues Beat; Offers FY19 EPS Mid-Point Guidance Above Consensus, FY19 Revenue Views Below Estimates

Integra LifeSciences Reports Fourth Quarter and Full-Year 2018 Financial Results and Provides 2019 Financial Guidance

February 21, 2019 6:00 AM EST

Fourth Quarter 2018 reported revenue increased 4.0% to $383.3 million; organic revenue increased 4.4%

Fourth Quarter 2018 GAAP earnings per diluted share were $0.29; adjusted earnings per diluted share were $0.65

The Company provides financial guidance for 2019 including total revenue in the range of $1.515 billion to $1.525 billion and organic revenue growth of approximately 5%

PLAINSBORO, N.J., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported financial results... More